What question did this study set out to answer?

This study aims to compare surgical outcomes between the hinotori and da Vinci robotic systems during radical prostatectomy.

Comparison of Surgical Outcomes Between the Hinotori and da Vinci Platforms in Robot‐Assisted Radical Prostatectomy: A Propensity Score‐Matched Study

View Full Paper

Ask AI

Bookmark

Authors

Propensity score-matched study comparing surgical outcomes in robotic prostatectomy platforms, suggesting no significant differences in key metrics.

This study aims to compare surgical outcomes between the hinotori and da Vinci robotic systems during radical prostatectomy.
Reviewed outcomes of 437 patients who underwent robot-assisted radical prostatectomy from 2013 to 2025.
Performed propensity score matching, analyzing 130 patients in the da Vinci group and 65 in the hinotori group.
Compared perioperative outcomes, positive surgical margin rates, urinary continence recovery, and biochemical recurrence-free survival.
Hinotori group had longer operative, console, and setup-related times; estimated blood loss was greater but no transfusions were needed.
No differences in overall or stage-specific positive surgical margin rates were noted between both groups.
12-month urinary continence recovery rates were 87% for hinotori and 85% for da Vinci; 2-year BCR-free survival rates were 94% vs. 89% at 1 year and 89% vs. 85% at 2 years.

Nishida et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Propensity score-matched study comparing surgical outcomes in robotic prostatectomy platforms, suggesting no significant differences in key metrics.

This study aims to compare surgical outcomes between the hinotori and da Vinci robotic systems during radical prostatectomy.
Reviewed outcomes of 437 patients who underwent robot-assisted radical prostatectomy from 2013 to 2025.
Performed propensity score matching, analyzing 130 patients in the da Vinci group and 65 in the hinotori group.
Compared perioperative outcomes, positive surgical margin rates, urinary continence recovery, and biochemical recurrence-free survival.
Hinotori group had longer operative, console, and setup-related times; estimated blood loss was greater but no transfusions were needed.
No differences in overall or stage-specific positive surgical margin rates were noted between both groups.
12-month urinary continence recovery rates were 87% for hinotori and 85% for da Vinci; 2-year BCR-free survival rates were 94% vs. 89% at 1 year and 89% vs. 85% at 2 years.

Nishida et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark